MrsMD

MrsMD operates as a physician-supervised weight loss and aesthetic wellness clinic in Atlanta, GA, delivering medical interventions that combine pharmacotherapy with nutritional guidance. The practice centers on FDA-approved GLP-1 receptor agonists and metabolic support therapies, providing structured programs for patients seeking measurable body composition changes under clinical oversight. Unlike subscription telehealth models, MrsMD requires in-person consultations to establish baseline health metrics, review contraindications, and design individualized treatment protocols that account for each patient's metabolic profile and weight loss history.

The clinic's pharmacological approach includes Semaglutide and Tirzepatide, both incretin mimetics that modulate appetite regulation and glucose metabolism through distinct receptor pathways. Semaglutide functions as a GLP-1 agonist, while Tirzepatide activates both GLP-1 and GIP receptors, offering dual incretin activity for patients who may benefit from enhanced metabolic signaling. MrsMD also incorporates NAD+ (nicotinamide adenine dinucleotide) supplementation into treatment plans, targeting cellular energy production and mitochondrial function as adjunctive support during caloric restriction phases. Dosing protocols follow evidence-based titration schedules, with providers adjusting medication strength based on tolerance, side effect profiles, and weekly weight trends documented during follow-up visits.

The medical team at MrsMD in Atlanta includes licensed physicians who conduct initial health assessments, order laboratory panels to screen for thyroid dysfunction or insulin resistance, and monitor patients throughout their weight loss progression. Providers evaluate candidacy for GLP-1 therapies by reviewing BMI thresholds, cardiovascular risk factors, and prior weight loss attempts, ensuring patients meet clinical criteria before initiating peptide-based interventions. The practice emphasizes patient education around medication mechanisms, expected timelines for appetite suppression, and strategies to maintain muscle mass during weight reduction, distinguishing its approach from programs that rely solely on prescription fulfillment without ongoing clinical engagement.

Patients attending MrsMD's Atlanta location participate in structured visits that include body composition analysis, nutritional counseling, and medication administration training for at-home injections. The clinic provides detailed instructions on subcutaneous injection technique, proper refrigeration of peptide medications, and recognition of gastrointestinal side effects common to incretin therapies. Follow-up schedules typically occur bi-weekly during dose escalation phases, transitioning to monthly monitoring once patients reach maintenance dosing. This hands-on model allows providers to adjust treatment variables in real time, addressing plateaus or adverse reactions through protocol modifications rather than automated refill systems.

MrsMD differentiates itself in the Atlanta wellness market by requiring face-to-face consultations rather than operating as a remote prescription service, a model that enables direct provider-patient communication and immediate clinical decision-making. The practice's aesthetic services complement weight loss programs, offering patients integrated care that addresses both metabolic health and cosmetic goals within a single clinical setting. With a 5.0-star rating across 19 Google reviews, the clinic has established a reputation for attentive service delivery and coordinated care, reflecting patient satisfaction with both clinical outcomes and the interpersonal aspects of treatment. For Atlanta residents seeking physician-guided weight management with Semaglutide, Tirzepatide, or NAD+ therapies, MrsMD provides a structured alternative to telehealth platforms, prioritizing in-clinic assessments and individualized protocol design.